1-2 of 2
Mercedes Sánchez-Barba
Close
Sort by
Journal Articles

New Score Prognostic System for Patients with MDS and Intermediate IPSS-R: Novel Algorithm to Distinguish Between Low and High Risk in This Subset of Patients. Results from the Spanish Group of MDS (GESMD). Gesmdi Score

Alba Redondo, MD PhD, Mercedes Sánchez Barba, PhD, Guillermo Sanz, MD, Teresa Bernal, MD PhD, Montserrat Arnan Sangerman, MD, Fernando Ramos, MD, Carmen Pedro, MD, Mª Luz Amigo Lozano, MD, Victor Marco, MD, David Valcárcel, MD PhD, Mª Teresa Ardanaz, MD, Salut Brunet, MD, Joan Bargay, MD, María Pedreño, MD, Ana I Vicente, PhD, María Teresa Cedena, MD, Mar Tormo, MD, Beatriz Arrizabalaga, MD, Blanca Xicoy, MD, Meritxell Nomdedeu, MD, Félix López Cadenas, MD, Carlos Fernández, MD, Juan Carlos Caballero, MD, Guillermo Martín, MD, María Consuelo Del Cañizo, MD PhD, María Díez Campelo, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4323.
https://doi.org/10.1182/blood.V128.22.4323.4323
Published: 2016
Journal Articles

Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT?

Juan Carlos Caballero, MD, Mercedes Sánchez-Barba, Mónica Del Rey, Kamila Janusz, Eva Lumbreras, María Abáigar, Robledo Cristina, Andrés Jerez, Esperanza Such, PhD, Guillermo Sanz, MD PhD, Cristina Calderon, MD, David Valcarcel, MD PhD, Jesus Maria Hernandez-Rivas, PhD, María Consuelo Cañizo, MD PhD, María Díez-Campelo, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2890.
https://doi.org/10.1182/blood.V126.23.2890.2890
Published: 2015